Clinical evaluation of efficacy of Ashwagandha on Quality of life in Geriatric Population- Prospective Double-blind placebo controlled study

Ministry of AYUSH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•i.Participants of scheduled Caste community irrespective of gender in the age group 60 to 75 years whose general health is stable with or without medication.
•ii.Participants willing to provide written informed consent and participate in the study for 3 months

•I.Participants with uncontrolled Hypertension with or without medication. (BP>= 160/100 mm of Hg)
•II.Participants with low blood pressure. (BP <=100/60mm of Hg)
•III.Participants with uncontrolled Diabetes mellitus with or without medication {HbA1c > 8%).
•IV.Participants with uncontrolled Hypothyroidism with or without medication (S. TSH >10mIU/ml)
•V.Participants with concurrent serious cardiac dysfunction or Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl), uncontrolled Pulmonary Dysfunction (Asthmatic and COPD patients) or any other concurrent severe disease.
•VI.Participants taking steroid treatment or any kind of immunosuppressive therapy.
•VII.Alcoholics and / drug abusers
•VIII.Participants participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
•IX.Participants who are taking Ayurvedic treatment/medicine for any disease condition for the last 3 months
•X.Participants with impaired cognition, or with a history or diagnosis of psychiatric illness and neurological disorders etc.
•XI.Any other condition which PI may think can jeopardize the study.

发起方